Quantcast
Tag archive for ‘FDA approval’
By The Dispatch On Sunday, September 8th, 2019
0 Comments

FDA approves Ofev for the treatment of scleroderma

By NewsDesk  @infectiousdiseasenews On Friday, the U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease More...

By The Dispatch On Tuesday, August 27th, 2019
0 Comments

Parkinson’s disease: FDA approves Nourianz as an add-on treatment

The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” More...

By Guest Author On Friday, August 9th, 2019
0 Comments

Xeljanz Class Action Lawsuit

What is Xeljanz? Xeljanz is a medication which is manufactured by Pfizer. It is approved for the treatment of Rheumatoid arthritis (RA), Psoriatic arthritis (PSA), Ulcerative colitis (US). These are tablets taken More...

By Guest Author On Thursday, November 8th, 2018
1 Comment

HGH Human Growth Hormone Review Uses & Side Effects

The human body produces a wide array of hormones, during different stages of life, in order to promote the proper growth and well-being of the body and the health in general. One of these hormones is known as Human More...

By The Dispatch On Wednesday, March 7th, 2018
0 Comments

Breast cancer: FDA okays direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

The U.S. Food and Drug Administration this week authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants). It is the first direct-to-consumer (DTC) test to report More...

By Guest Author On Sunday, May 21st, 2017
1 Comment

Dietary Supplements: The Face of a Self-Regulating Industry

The pressure to look great weighs heavily on many. From people who want to lose weight to improve their overall health to those who want to lose weight to fit their ideal beauty standards, the dietary supplement More...

By The Dispatch On Saturday, December 17th, 2016
0 Comments

Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)

Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine.  More...

By Laura Jones On Thursday, March 31st, 2016
0 Comments

FDA passes Mifeprex changes, reducing cost for abortions despite risk to women

The Food and Drug Association (FDA) changed the regimen for mifepristone (Mifeprex), significantly reducing the obstacles, burden, and cost to abortionists. The move includes approval of new labeling for the abortion More...

By The Dispatch On Monday, November 30th, 2015
0 Comments

Bristol-Myers Squibb’s, Empliciti, receives approval for the treatment of multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Multiple More...

By The Dispatch On Monday, November 23rd, 2015
1 Comment

Opdivo receives FDA nod to treat advanced form of kidney cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. Photo/Madhero88 More...

By The Dispatch On Thursday, November 5th, 2015
0 Comments

HIV treatment, Genvoya, gets FDA nod

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment More...

By The Dispatch On Monday, September 14th, 2015
1 Comment

ADF files brief to make New Hampshire funding of Planned Parenthood records public

Alliance Defending Freedom attorneys filed a brief with the New Hampshire Supreme Court Wednesday to release all documents related to the state’s funding of abortion facilities and its continuing failure to regulate More...

By Guest Author On Tuesday, September 8th, 2015
0 Comments

Prevalent Poison: The Shocking Stats Behind Nursing Home Drugging

When people send their loved ones to a nursing home, they expect that they will be taken care of. But, some new findings suggest that elderly patients are being abused in these facilities. Here are some ways to More...

By Brandon Jones On Friday, August 21st, 2015
2 Comments

How the Mark of the Beast arrived in the 21st Century

It’s always easy for Christians in 2015 to proudly proclaim how they’ll refuse the “Mark of the Beast” as described in the Bible. These Christians never account or analyze how desperate they More...

By The Dispatch On Friday, January 9th, 2015
2 Comments

Blood clot prevention drug, Savaysa, gets FDA approval

The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation More...

By The Dispatch On Tuesday, December 23rd, 2014
2 Comments

Novo Nordisk’s Saxenda receives FDA approval for chronic weight management treatment

The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The More...

By The Dispatch On Sunday, October 26th, 2014
0 Comments

FDA approves Obizur for treating hemophilia A bleeding episodes in adults

The U.S. Food and Drug Administration approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] More...

By The Dispatch On Thursday, September 18th, 2014
0 Comments

Diabetes drug, Trulicity, receives FDA approval

The U.S. Food and Drug Administration today approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type More...

By Guest Author On Tuesday, August 19th, 2014
1 Comment

Vacations and Health – The new winning formula for travelers abroad

Many people around the world who simply cannot afford to undergo a medical procedure at home, due to a complex medical procedure or a simple cosmetic one, have got an opportunity to go to a foreign country and have More...

By The Dispatch On Wednesday, August 13th, 2014
0 Comments

Sleep drug, Belsomra, gets FDA nod

The U.S. Food and Drug Administration today approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra is an orexin receptor antagonist and is More...


Recent Posts

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

October 15, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History